ImCheck

CheckmAb

This biotechnology company develops monoclonal antibody therapies for cancer and autoimmune disease patients by targeting regulatory T cells within pathological tissues.

Re-Aim Therapeutics

This early-stage biotechnology company develops antibody-based therapies that target and deplete disease-causing cells to treat patients with autoimmune and inflammatory disorders.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Immunocore

This biotechnology company develops T cell receptor immunotherapies to treat patients with cancer, infectious diseases and autoimmune conditions.

Advesya

This biotech company develops immunotherapies and antibody-drug conjugates targeting IL-1RAP for patients with cancer and autoimmune diseases.

immunique

This company develops immune therapeutics, including cell therapies and peptides, for patients with cancer and autoimmune diseases.

T-Therapeutics

The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.

Ankyra Therapeutics

This biotechnology company develops anchored immunotherapy treatments for patients with cancer and other serious immune-mediated diseases.